We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

T Cell Response in Hypersensitivity Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00213447
Recruitment Status : Completed
First Posted : September 21, 2005
Last Update Posted : June 18, 2013
Information provided by (Responsible Party):
University Hospital, Rouen

Brief Summary:
immunological study of the T cell repertoire phenotype and functionality in hypersensitivity syndrome.

Condition or disease
Hypersensitivity Syndrome

Study Type : Observational
Estimated Enrollment : 40 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Characterization of T Cell Response in Hypersensitivity Syndrome
Study Start Date : November 2002
Estimated Study Completion Date : December 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Allergy
U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with Drug rash with eosinophilia and systemic symptoms

Inclusion Criteria:

  • age > 18
  • cutaneous eruption
  • lymph nodes
  • hepatitis
  • interstitial pneumonia
  • nephritis
  • cardiopathy
  • eosinophilia
  • hyperlymphocytosis

Exclusion Criteria:

  • age minor to 18
  • HIV +

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00213447

Rouen, France
Sponsors and Collaborators
University Hospital, Rouen
Principal Investigator: Pascal Joly, MD-PHD UH rouen

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: University Hospital, Rouen
ClinicalTrials.gov Identifier: NCT00213447     History of Changes
Other Study ID Numbers: 2001/056/HP
First Posted: September 21, 2005    Key Record Dates
Last Update Posted: June 18, 2013
Last Verified: June 2013

Additional relevant MeSH terms:
Drug Hypersensitivity Syndrome
Pathologic Processes
Immune System Diseases
Drug Eruptions
Skin Diseases
Drug Hypersensitivity
Drug-Related Side Effects and Adverse Reactions
Chemically-Induced Disorders